Equities

Option Care Health Inc

Option Care Health Inc

Actions
  • Price (USD)31.55
  • Today's Change0.44 / 1.41%
  • Shares traded1.90m
  • 1 Year change-7.48%
  • Beta1.2978
Data delayed at least 15 minutes, as of Sep 19 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Sep-23
  • 20-Jun-24
  • 18-Jul-24
  • 15-Aug-24
  • 12-Sep-24
Select bar for recommendation details.
Recommendations12-Sep-24
Buy4
Outperform5
Hold0
Sell0
Strong Sell0

Share price forecast in USD

The 8 analysts offering 12 month price targets for Option Care Health Inc have a median target of 39.00, with a high estimate of 43.00 and a low estimate of 36.00. The median estimate represents a 23.61% increase from the last price of 31.55.
High36.3%43.00
Med23.6%39.00
Low14.1%36.00

Earnings history & estimates in USD

On Jul 31, 2024, Option Care Health Inc reported 2nd quarter 2024 earnings of 0.300 per share. This result exceeded the 0.270 consensus of the 9 analysts covering the company and under-performed last year's 2nd quarter results by 52.38%.
The next earnings announcement is expected on Oct 23, 2024.
Average growth rate-12.73%
Option Care Health Inc reported annual 2023 earnings of 1.48 per share on Feb 22, 2024.
Average growth rate+59.31%
More ▼

Revenue history & estimates in USD

Option Care Health, Inc. had 2nd quarter 2024 revenues of 1.23bn. This bettered the 1.17bn consensus of the 9 analysts covering the company. This was 20.80% above the prior year's 2nd quarter results.
Average growth rate+3.53%
Option Care Health, Inc. had revenues for the full year 2023 of 4.30bn. This was 9.06% above the prior year's results.
Average growth rate+17.11%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.